Chronic obstructive pulmonary disease

I work as a respiratory therapist and treat patients diagnosed with chronic obstructive pulmonary disease (COPD). Smoking is a leading cause associated with developing COPD. As a professional working in the healthcare field, I have been fortunate and educated about the dangers and consequences linked to cigarette smoking. I have treated and have experience with individuals who have smoked and developed COPD. Also, as an educator, I have tried to help individuals quit smoking to improve overall

Chronic obstructive pulmonary disease (COPD) is one of the most common types of lung disease that includes emphysema and chronic bronchitis. This abnormal lung inflammatory response is characterized by a persistent airflow obstruction, which is not fully reversible (Lee, Kim, & Tagmazyan, 2013). COPD is a major public health problem as it causes major disability, morbidity, and mortality. Moreover, economic consequences of COPD are substantial. In 2010, the estimated total societal cost of COPD

Matt McGuire Dr. Wilson 25 November 2014 Chronic Bronchitis Chronic obstructive pulmonary disease (COPD) affects an estimated 24 million individuals in the United States, where half of these people do not even know they have it (COPD Foundation 2014). COPD governs a deluge of ailments including: emphysema, refractory asthma, some forms of bronchiectasis, and the very prevalent chronic bronchitis. Chronic Bronchitis is a long-term pulmonary disease where there is a problem in the airway of the lungs

According to Gold Expert Panel (2003) Chronic Obstructive Pulmonary Disease (COPD) is a slowly progressive disorder characterized by airflow obstruction that is not fully reversible. COPD is also known as an Exacerbation where it is frequently linked to lung infection that caused by a virus or bacteria. In addition, it is often a combination of Chronic Bronchitis and Emphysema which can mainly result altogether in coughing, wheezing, chest tightness, shortness of breath and other symptoms. However

provided; the three differential diagnosis that are being considered include; chronic obstructive pulmonary disease (COPD), bronchitis and community acquired pneumonia (CAP) (Papadakis, McPhee, & Rabow, 2015). COPD Symptoms of COPD often begin in middle age and is commonly caused by years of smoking. COPD is progressive, irreversible and made up of chronic bronchitis and emphysema (Goolsby & Grubbs, 2011). Symptoms include; chronic productive cough for three consecutive months each year for 2 sequential

COPD, or Chronic Obstructive Pulmonary Disease, is one of the most common lung diseases. Thousands of people are diagnosed every year, and it recently moved up to the 3rd leading cause of death in the U.S., behind heart disease and cancer. This paper will discuss disease pathology, the most common and recently discovered diagnostic tests, as well as treatment options. It will also address end of life care. COPD is a multi-system and multi-symptom disease. This means that it attacks the respiratory

2020, Chronic Obstructive Pulmonary Disease (COPD) is poised to be the third leading cause of death worldwide (Global Initiative for Chronic Obstructive Lung Disease [GOLD], 2017). Unlike most of the other diseases, COPD’s mortality rate is rising (GOLD, 2017). This paper aims to define COPD and its prevalence in Australia and China. A couple of prevention and treatment strategies will also be examined in the paper. 2.0 Definition of COPD COPD is a serious, non-communicable respiratory disease (Australian

Over the years Chronic Obstructive Pulmonary Disease (COPD) has been a vastly under-identified and under-treated, causing the World Health Organization (WHO) to undertake increased worldwide awareness concerning the disease. Thus the Global Initiative for Chronic Obstructive Lung Disease (GOLD) was created in order to educate the world and set standardized practices.1,2 COPD is defined by the chronic obstruction of the airway relating to inflammatory diseases of the bronchial tubes. The restrictive

providers alike face substantial challenges in effectively managing Chronic Obstructive Pulmonary Disease (COPD) in the primary care setting. The Agency for Healthcare Research and Quality (AHRQ) has provided statistical evidence in its 2013 National Healthcare Disparities Report that some populations bear a disproportionate burden of incidence and complications derived from COPD (AHRQ, 2013). Chronic lower respiratory diseases, including asthma and COPD, were associated with a total of 143,382

R.S.’s chronic obstructive pulmonary disease (COPD), he’s going to be experiencing the many consequences of his type B COPD, otherwise known as chronic bronchitis. Copstead & Banasik (2013) states that the pathogenesis for chronic bronchitis has changes in the airways that include swelling and chronic inflammation of the bronchial mucosa which can lead to scarring. In addition, there is hypertrophy of mucosal glands and goblet cells, which leads to increased mucosal production. In chronic bronchitis